Spectral AIMDAI -0.58%6 Current Ratio is 0.75 as of Mar. 2026, which is 13% below its 10-year median of 0.86. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.91 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Spectral AI ranks worse than 91.91% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Spectral AI's current ratio for the quarter that ended in Mar. 2026 was 0.75.
Spectral AI has a current ratio of 0.75. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Spectral AI has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Spectral AI's Current Ratio or its related term are showing as below:
MDAI'
s Current Ratio Range Over the Past 10 Years
Min: 0.57 Med: 0.86 Max: 3.86
Current: 0.75
During the past 5 years, Spectral AI's highest Current Ratio was 3.86. The lowest was 0.57. And the median was 0.86.
MDAI's Current Ratio is ranked worse than 91.91% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs MDAI: 0.75
Spectral AI (NAS:MDAI) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Spectral AI Current Ratio Related Terms
Spectral AI Current Ratio Historical Data
* Premium members only.
The historical data trend for Spectral AI's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Spectral AI's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spectral AI Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spectral AI's Current Ratio distribution charts can be found below:
* The bar in red indicates where Spectral AI's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spectral AI (MDAI) has a Current Ratio of 0.75 as of Mar. 2026. This is 13% below median its historical median of 0.86. Over the past decade, Spectral AI's Current Ratio has ranged from 0.57 to 3.86. According to the industry distribution chart, Spectral AI ranks #784 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 91.9%.
Is Spectral AI's Current Ratio too high?
Spectral AI's current Current Ratio of 0.75 is 13% below median its 10-year median of 0.86. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 3.86. The Medical Devices & Instruments industry median Current Ratio is 2.49. Spectral AI's value of 0.75 is 69.9% below this industry median. Based on the distribution chart, Spectral AI ranks #784 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's Current Ratio compare to LUNG and QTI?
According to the Medical Devices & Instruments industry distribution chart, Spectral AI ranks #784 out of 853 companies for Current Ratio. This places Spectral AI in the lower half of its industry. The industry median Current Ratio is 2.49. Spectral AI's value of 0.75 is 69.9% below this benchmark. Historically, Spectral AI's own Current Ratio has ranged from 0.57 to 3.86 over the past decade. While the company's 10-year median is 0.86 vs. the industry median of 2.49, Spectral AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spectral AI's current Current Ratio of 0.75 is 69.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spectral AI's current Current Ratio is 0.75, which is 13% below median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.91, compared to a current price of $1.72 — trading 89% above its estimated fair value. The current Current Ratio is 0.75, which is 13% below median its 10-year median of 0.86 and 69.9% below the Medical Devices & Instruments industry median of 2.49. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Spectral AI (MDAI), the current Current Ratio is 0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spectral AI (MDAI) Overvalued in 2026?
Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued.
The current stock price of $1.72 is trading 89% above its estimated GF Value™ of $0.91.
GuruFocus considers Spectral AI to be Significantly Overvalued.
Key valuation signals for MDAI:
Current Ratio: 0.75 (13% below median its 10-year median of 0.86)
GF Value™: $0.91 vs. price of $1.72 (89% above fair value)
Industry Position: 69.9% below the Medical Devices & Instruments median (#784 of 853)
No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score
Get the complete analysis for MDAI
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDAI has been successfully added to your 
